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Visual Diagnosis of Dermatological Disorders:
Human and Machine Performance
Jeremy Kawahara and Ghassan Hamarneh
Abstract—Skin conditions are a global health concern, ranking
the fourth highest cause of nonfatal disease burden when mea-
sured as years lost due to disability. As diagnosing, or classifying,
skin diseases can help determine effective treatment, dermatolo-
gists have extensively researched how to diagnose conditions from
a patient’s history and the lesion’s visual appearance. Computer
vision researchers are attempting to encode this diagnostic ability
into machines, and several recent studies report machine level
performance comparable with dermatologists.
This report reviews machine approaches to classify skin
images and consider their performance when compared to
human dermatologists. Following an overview of common image
modalities, dermatologists’ diagnostic approaches and common
tasks, and publicly available datasets, we discuss approaches to
machine skin lesion classification. We then review works that
directly compare human and machine performance. Finally, this
report addresses the limitations and sources of errors in image-
based skin disease diagnosis, applicable to both machines and
dermatologists in a teledermatology setting.
I. INTRODUCTION
Skin disorders are the most frequent reason to visit a general
practitioner in studied populations [1] and are a recognized
global health burden [2]. In 2013, approximately one in four
Americans saw a physician for at least one skin condition [3].
As correctly diagnosing, or classifying, skin conditions can
help narrow treatment options, dermatologists have extensively
researched how to classify skin conditions from a patient’s
history and the visual properties of skin lesions. However,
skin diseases are difficult to diagnose [4], and studies suggest
an unmet demand for dermatologists [5]. To alleviate these
challenges, computer vision researchers are attempting to
encode this diagnostic ability into machines [6], which may
lead to more reproducible and accessible diagnoses in under-
served communities.
The following section provides an overview of the common
imaging modalities, tasks, typical diagnostic approaches used
by dermatologists, and common datasets and metrics used to
evaluate the performance of automated skin disease diagnosis.
Section II reviews trends in machine approaches to classify
skin diseases. Section III presents works that directly compare
humans and machine skin disease classification. Finally, Sec-
tion IV discusses the performance of humans and machines.
A. Non-Invasive Imaging Modalities of the Skin
The two common non-invasive imaging modalities to ac-
quire skin images are clinical and dermoscopy images (Fig. 1).
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Clinical images capture what is seen with the unaided human
eye and can be acquired at varying fields-of-view using non-
standard cameras. Dermoscopy (also referred to as epilumi-
nescence microscopy [7]) images show a magnified view of
intra- and sub-epidermal structures and are acquired using a
dermatoscope, which offers a more controlled field-of-view.
Dermoscopy images are commonly used to help differentiate
benign from malignant lesions, whereas clinical images, with
their flexible field-of-view, are more commonly used to im-
age general skin diseases. While other non-invasive imaging
modalities, such as ultrasound, have been used for skin lesion
diagnosis [8], this survey focuses on clinical and dermoscopy
images. For this report, non-image information acquired from
the patient is defined as the patient history, which includes
factors such as patient age, sex, lesion location, family history,
and environmental factors.
B. Diagnosing Skin Diseases
Diagnosing skin diseases is complicated. There are at least
3,000 identified varieties of skin diseases [10] with a preva-
lence that varies by condition. The “gold standard” for skin
disease diagnosis is determined through a biopsy, where a
portion of the affected skin specimen is extracted and sent to
dermatopathologists for analysis [4]. However, biopsy requires
additional time and cost to extract and analyze the lesion, and
may introduce potential complications to the patient. Wahie
et al. [11] reported that 29% of patients had complications
after a skin biopsy, mainly as a result of infection. Thus
dermatologists may avoid biopsy in cases with well-recognized
symptoms and instead rely on data collected non-invasively.
Dermatologists consider a variety of factors in their diag-
noses, including patient history and the appearance (e.g., mor-
phology, colour, textures) of the affected skin region. En-
tire textbooks describe approaches to diagnose skin lesions
(e.g., [12]), where the methods are often specific to distinct
types of dermatological conditions. For example, to classify
skin diseases that manifest as stains on the skin, flowcharts
that encode visual properties, patient history, and the lesion’s
location on the body can aid in the diagnosis [13].
Melanoma, which accounted for 41% of skin related deaths
in the United States in 2013 [3], receives special attention due
to the mortality risk. To aid less experienced clinicians in rec-
ognizing melanoma from benign lesions, rule-based diagnostic
systems have been proposed, such as the ABCD rule [14]
and the 7-point checklist [15]. These simplified rule-based
systems produce a melanoma score based on the physician
recognizing the presence of melanoma-specific morphological
characteristics within the lesion.
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NEV NEV SK SK BCC BCC MEL MEL
Fig. 1: The same lesion (column) can be captured as a dermoscopy (top row) and a clinical image (bottom row). Dermoscopy
offers a more standardized acquisition, while clinical images can capture a wider field of view. These sampled images [9]
show the variability of some common lesions, where nevi (NEV) and seborrheic keratoses (SK) are benign conditions, and
basal cell carcinoma (BCC) and melanoma (MEL) are common cancers.
(a)
(b)
(c)
(d)
Fig. 2: Common dermatological tasks: (a) classify the observed
skin lesion directly from the image; (b) segment the lesion
from the background; and, detect the presence of dermoscopic
criteria (e.g., (c) pigment network and (d) streaks).
General practitioners receive less training in dermatology
than dermatologists and are often the first point of contact
for skin conditions. Ru¨bsam et al. [16] found that general
practitioners reported diagnosing dermatological problems us-
ing various strategies: visual recognition, testing of different
treatments, and refining the diagnosis via asking additional
questions. Sellheyer et al. [4] reported that dermatologists
correctly diagnosed roughly twice the number of cases when
compared to non-dermatologists, using the histopathology
diagnoses as the reference.
C. Common Non-Invasive Dermatology Tasks
1) Classify Skin Diseases: As previously discussed, to diag-
nose or classify a skin disease, a physician or machine predicts
the type of skin disease by analyzing the patient’s history, the
visual properties of skin lesions, or both. Automated machine
approaches to classify skin diseases is discussed in detail
in Section II. While it is possible to estimate the disease
class from the image directly, this process, especially during
machine classification, has traditionally been broken into the
following sub-tasks.
2) Classify Dermoscopic Criteria: The existence of certain
visual properties within a lesion may indicate a condition. For
example, the presence of certain dermoscopic criteria (such
as an atypical pigment network or irregular streaks) within
a lesion is indicative of melanoma. Thus, one approach to
classify melanoma is to classify dermoscopic criteria known
to be associated with melanoma. If a lesion contains a number
of these criteria, a diagnosis of melanoma can be inferred [15].
Approaches to classify dermoscopic criteria are discussed in
Section II-B.
3) Lesion Segmentation: Lesion segmentation, i.e., delin-
eating the boundary of a lesion in an image (Fig. 2b), allows
for lesion properties to be carefully measured, and is often
used to extract image features that rely on knowing the border
of the lesion. Several of the works discussed in Section II
segment the lesion prior to classification.
4) Detect Dermoscopic Criteria: A specific dermoscopic
criteria (e.g., streaks, which are associated with melanoma)
can be both localized and classified (Fig. 2c and Fig. 2d).
While this task is similar to classifying dermoscopic criteria
(Sec. I-C2), detecting dermoscopic criteria requires localiza-
tion. This task may allow physicians to localize those areas
containing disease-specific criteria.
5) Artefact Removal: Artefact removal involves discarding
potentially confounding properties from the images, and is
often a preprocessing step that precedes the aforementioned
tasks. For example, applying colour constancy to control for
illumination [17], and removing specular highlights [18] or
hair [19], [20] from images may improve lesion segmentation
or classification.
D. Common Skin Condition Image Datasets
As diagnostic difficulty varies by image and type of condi-
tion, standardized datasets provide a valuable way to bench-
mark different approaches. Here we discuss commonly used
and publicly available datasets suitable for classifying skin
conditions from images.
1) Atlas of Dermoscopy: The Atlas of Dermoscopy, also
know as the EDRA atlas, was originally released as a tool
to instruct physicians to diagnose skin lesions and recognize
dermoscopic criteria related to melanoma [9]. This dataset pro-
vides 1,011 cases of skin lesions, with corresponding clinical
and dermoscopy images for nearly every case, patient history
(e.g., age, sex), and ground truth diagnoses and dermoscopic
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TABLE I: Details of the Atlas of Dermoscopy dataset. The two left columns show the labels for each criteria in the 7-point
checklist. The right column shows the labels that correspond to the overall diagnoses. The 7pt column indicates the contribution
to the 7-point checklist score, where a non-zero score indicates a criteria label associated with melanoma. The #cases column
indicates the number of cases with the specific label.
Name 7pt #cases Name 7pt #cases Name #cases
1. Pigment Network 5. Vascular Structures Diagnosis
absent 0 400 absent 0 823 Basal Cell Carcinoma 42
typical 0 381 arborizing 0 31 Blue Nevus 28
atypical 2 230 comma 0 23 Clark Nevus 399
2. Regression Structures hairpin 0 15 Combined Nevus 13
absent 0 758 within regression 0 46 Congenital Nevus 17
blue areas 1 116 wreath 0 2 Dermal Nevus 33
white areas 1 38 dotted 2 53 Recurrent nevus 6
combinations 1 99 linear irregular 2 18 Reed or Spitz Nevus 79
3. Pigmentation 6. Dots and Globules Melanoma 252
absent 0 588 absent 0 229 Dermatofibroma 20
diffuse regular 0 115 regular 0 334 Lentigo 24
localized regular 0 3 irregular 1 448 Melanosis 16
diffuse irregular 1 265 7. Streaks Miscellaneous 8
localized irregular 1 40 absent 0 653 Vascular Lesion 29
4. Blue Whitish Veil regular 0 107 Seborrheic Keratosis 45
absent 0 816 irregular 1 251
present 2 195 Total Cases 1011
criteria labels. Table I provides details on the number of cases
available for each dermoscopic criteria and diagnosis. This
dataset is available online [21].
TABLE II: The number of images for each skin disease type
in the Dermofit Image Library.
Name # imgs Name # imgs
Actinic Keratosis 45 Malignant Melanoma 76
Basal Cell Carcinoma 239 Melanocytic Nevus 331
Dermatofibroma 65 Pyogenic Granuloma 24
Haemangioma 97 Seborrhoeic Keratosis 257
Intraepithelial Carcinoma 78 Squamous Cell Carcinoma 88
2) Dermofit Image Library: The Dermofit Image Li-
brary [22] is available online [23] and consists of 1,300
clinical images covering 10 classes of skin lesions (described
in Table II). Images are captured in a standardized way, con-
trolling for illumination and distance to the lesion. Manually
segmented lesions are also available.
TABLE III: The diagnosis, dermoscopic criteria, and the
number of images with each label in the PH2 dataset.
Name #imgs Name #imgs Name #imgs
Diagnosis 3. Dots/Globules 6. Asymmetry
Common Nevus 80 Absent 87 Fully Symmetric 117
Atypical Nevus 80 Atypical 59 Asymmetry in One Axis 31
Melanoma 40 Typical 54 Fully Asymmetry 52
1. Pigment Network 4. Streaks 7. Colors
Atypical 116 Absent 170 White 19
Typical 84 Present 30 Red 10
2. Blue Whitish Veil 5. Regression Areas Light-Brown 139
Absent 164 Absent 175 Dark-Brown 156
Present 36 Present 25 Blue-Gray 38
Black 42
3) PH2: PH2 is a publicly available [24] dataset of 200
dermoscopy images of skin lesion. Each lesion was manually
segmented and expertly labeled with a diagnosis and seven
dermoscopic criteria [25], [26]. These dermoscopic criteria are
a subset of the 7-point checklist [15] and includes additional
criteria relevant to other diagnostic procedures (e.g., ABCD
rule [14]). Table III shows the number of images labeled with
each diagnosis and dermoscopic criteria.
TABLE IV: The diagnosis labels for the HAM10000 dataset.
Name # imgs
Actinic Keratosis & Intraepithelial Carcinoma 327
Basal Cell Carcinoma 514
Benign Keratosis 1099
Dermatofibroma 115
Melanoma 1113
Melanocytic Nevus 6705
Vascular Lesion 142
4) ISIC Challenge: The ISIC Challenge is a public derma-
tology competition with three tasks: segment lesions; detect
dermoscopic criteria; and classify lesions (as described in Sec-
tion I-C). The challenge has run in 2016 [27], 2017 [28], and
2018 [29]. The dataset contains dermoscopy images, lesion
segmentation masks, and dermoscopic criteria masks. Each
task has standard evaluation metrics and training, validation,
and testing dataset partitions. In 2018, the ISIC skin lesion
classification challenge used the HAM10000 dataset [30] as
the training set, which provides 10,015 dermoscopy images
covering seven diagnosis categories. Table IV shows the
number of images with each diagnosis label in the HAM10000
dataset.
5) SD Clinical Dataset: The SD-198 dataset [31] consists
of 6,584 clinical images covering 198 fine-grained categories
of skin diseases, where each category has between 10 and
60 images [32]. Images were collected from the website
DermQuest [33]. SD-128 is a subset of SD-198 and consists of
5,619 clinical images, where each class has at least 20 images.
6) Others: The Skin Cancer Detection dataset [34] provides
119 melanoma and 87 non-melanoma clinical images along
with lesion segmentation masks, which were gathered from
two online sources: the Dermatology Information System [35]
and DermQuest [33]. The MED-NODE dataset [36], [37]
provides 70 melanoma and 100 nevi clinical images. The
Melanoma Classification Benchmark [38], [39] sourced 100
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Fig. 3: Computing common classification metrics. (a) Given
a confusion matrix of three-classes, accuracy is computed
by dividing the sum of the diagonal cells (red) with the
total number of samples within all cells. (b) Considering
“A” as a positive class, the blue cell indicates true positives,
orange cells indicate false negatives, green cells indicate false
positives, and pink cells indicate true negatives. (c) The
AUROC curve with respect to a single class “A”. Discrete
predictions (e.g., red point) may have a different ROC curve
than probabilistic predictions (green line). The values in the
legend are the AUROC of the corresponding curves.
dermoscopy images from the ISIC challenge [27] and 100 clin-
ical images from the MED-NODE dataset [36] such that for
each type of image, 80 images are of benign nevi and 20 are
of melanoma. The diagnostic performance of dermatologists
over the same dataset is also provided (157 dermatologists for
dermoscopy images, 145 dermatologists for clinical images).
E. Common Metrics for Classification
Measuring the performance of a classifier on a diagnostic
task is complicated as there are multiple classes of diseases,
datasets are often imbalanced, and the clinical penalty for
misdiagnosis may differ.
Accuracy is a common metric that measures the fraction
of cases where the predicted diagnoses yˆ correctly matches
the true diagnoses y. Some clinical studies (e.g., [40]) report
results that include a differential diagnosis (i.e., when a
physician makes more than one disease diagnosis), where the
prediction is considered correct if any of the K diagnoses
match the true diagnosis. The top-K accuracy is defined as,
accuracy(yˆ, y,K) =
1
N
N∑
i=1
K∑
k=1
δ(yˆ(i), y
(i)
k ) (1)
where there are N cases; δ(a, b) is the Kronecker delta
function which returns 1 if a = b, else 0; y(i) is the true
diagnosis for the i-th case; and, yˆ(i)k is the k-th predicted
differential diagnosis of the i-th case. Given a confusion matrix
of the predicted and true labels, the top-1 accuracy can be
computed by dividing the sum of the diagonal values by N
(Fig. 3a).
Other common metrics for classification problems are sen-
sitivity,
sensitivity(yˆ, y, c) =
TP(yˆ, y, c)
TP(yˆ, y, c) + FN(yˆ, y, c)
(2)
and specificity,
specificity(yˆ, y, c) =
TN(yˆ, y, c)
TN(yˆ, y, c) + FP(yˆ, y, c)
(3)
where each metric is computed with respect to a class label c
(e.g., a diagnosis y may have C possible class labels). Given
c as the positive class label, the number of true positives, false
positives, true negatives, and false negatives are computed as,
TP(yˆ, y, c) =
N∑
i=1
(
δ(yˆ(i), c) · δ(y(i), c)
)
(4)
FP(yˆ, y, c) =
N∑
i=1
(
δ(yˆ(i), c) · (1 − δ(y(i), c))
)
(5)
TN(yˆ, y, c) =
N∑
i=1
(
(1 − δ(yˆ(i), c)) · (1 − δ(y(i), c))
)
(6)
FN(yˆ, y, c) =
N∑
i=1
(
(1 − δ(yˆ(i), c)) · δ(y(i), c)
)
(7)
respectively. Fig. 3b shows an example using a confusion
matrix.
Another metric used to measure the performance over
a public skin dataset is balanced accuracy. This metric is
equivalent to the sensitivity averaged across classes,
sensitivity(yˆ, y) =
1
C
C∑
c=1
sensitivity(yˆ(i), y(i), c) (8)
where C is the number of unique classes. The averaged
sensitivity assumes an equal importance for each class and
may be more suitable for imbalanced datasets than accuracy
(Eq. 1), as accuracy assumes an equal importance for each
image.
The area under the receiver operator characteristic curve
(AUROC) considers the sensitivity and specificity for a given
positive class c over all thresholds of the model’s predicted
probabilities (Fig. 3c). The area under the resulting ROC curve
is a commonly reported metric in skin lesion classification
studies [28], [41], [42]. As the AUROC curve considers all
decision thresholds, this metric is sensitive to the predicted
probabilities.
One challenge that arises when comparing the performance
of humans and machines is that humans, in general, report a
single discrete prediction, while machines give a probability
distribution. Specifically, the predicted label yˆ(i) of the i-
th lesion is defined as the most probable label within the
predicted probability distribution p(i),
yˆ(i) = j∗ = argmax
j∈{1,...,C}
p
(i)
j (9)
where C is the number of classes, and p(i)j is the j-th class
probability of the i-th lesion.
When computing the AUROC curve for a human, the
sensitivity and specificity of the predictions are used and
the ROC curve is assumed to be linear (see Fig. 3c). In
contrast, the probabilistic outputs of machines often produce
non-linear ROC curves (e.g., [41]). In addition, while the
ROC curve demonstrates the limits of the model’s ability to
discriminate [43], this considers all possible probability thresh-
olds, rather than the actual predictions. Thus a probabilistic
model that makes incorrect predictions can still achieve a high
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AUROC score. Further, in a multi-class scenario where the
non-positive classes are all considered negative, a ROC curve
may be influenced by class imbalances [44].
While other metrics, such as average precision, are
used [27], [45], they are reported less frequently in the
literature. In order to compare human and machine predictions
over multi-class datasets across a variety of works, we focus
on reviewing experiments within studies where diagnostic ac-
curacy can be inferred. Limitations when relying on diagnostic
accuracy are discussed in Section IV-A.
II. MACHINE SKIN DISEASE CLASSIFICATION
This section primarily focuses on skin disease classification
and discuss other tasks (e.g., segmentation) in the context of
supporting classification. A classification system is seen as a
pipeline or model φ and parameters θ of φ, and generally
requires a dataset of the observable input data x (e.g., images,
patient history), and, for training or evaluation, the desired out-
put data y (e.g., disease diagnosis). To design a classification
system, a general optimization is done,
φ∗, θ∗ = argmin
φ,θ
E(φ(x; θ), y) (10)
where φ(·) is a model or pipeline that transforms the input data
x into a predicted output yˆ = φ(·), such that yˆ matches the
desired output y. θ are the parameters for the model/pipeline;
E(·) measures the error between the predicted yˆ and true
output y, and can encode prior knowledge about the output or
model parameters (e.g., regularization). φ∗, θ∗ are the found
model/pipeline and parameters, respectively, that minimize
(globally or locally) E(·). There are many ways to optimize
Eq. 10 as can be found in recent surveys [46]–[52]. A common
approach is for a human to design a fixed model/pipeline
φ, and to learn the parameters θ from the data using an
explicit optimization (e.g., gradient descent). In the following
sections, we discuss common pipelines/models, parameters,
and optimization approaches, where each proposed component
can be thought to be part of the general optimization of Eq. 10.
A. Sequential Pipeline Approach
Celebi et al. [53] proposed the following general pipeline φ
to classify dermoscopy images as either benign or melanoma:
1) segment the skin lesion; 2) extract colour and shape-based
features from the lesion border and regions within the lesion;
3) select a subset of discriminative features; and 4) use a
machine learning classifier to distinguish among the classes.
Related to Eq. 10, the pipeline and design choices φ are chosen
by the authors (e.g., types of colour features to extract [54]),
while the learned parameters θ are explicitly optimized by a
support vector machine classifier (SVM).
This is referred to as a sequential pipeline approach since it
follows a series of well-defined steps, where the fixed output
from one step becomes the input to another (Fig. 4).
Many existing works propose a variation on this sequential
pipeline, where a step may be improved or omitted. For
example, Ballerini et al. [22], [55] used 960 clinical images
from the Dermofit dataset (Sec. I-D2) to classify among five
Logistic 
Regression
• Hair
• Illumination
• Specular highlights
2. Segment 
lesion
3. Extract 
features
4. Select 
features 5. Classify
1. Remove 
artefacts
• Graph cuts
• Semantic CNN
• General
• Engineered
• Learned
• Sequential 
forward 
selection
Convolutional 
Neural Network
Fig. 4: A common general pipeline to classify skin diseases.
Image features can be extracted, then sent to a classifier
(e.g., logistic regression). CNNs can extract features and
classify diseases directly from images, but may also be used
to extract features.
types of skin lesions with a 74.3% accuracy. They segmented
lesions using a region-based active contour approach, extracted
human engineered colour and texture features from the le-
sion and healthy skin separately, and selected features using
sequential forward feature selection [56]. A hierarchical k
nearest neighbour classifier clusters the images into two high-
level classes (benign vs. pre-malignant and cancer), followed
by another classification to determine the sub-classes. Leo et
al. [57] evaluated over 1,300 images of Dermofit composed
of 10-classes, and followed a similar approach to achieve a
classification accuracy of 67%. Shimizu et al. [58] segmented
lesions and removed artefacts using a colour thresholding
based approach. They extracted 828 colour and texture features
based on the sub-regions of the segmented lesions, applied
feature selection to select a subset of discriminative features,
and used a two-stage hierarchical linear classifier to classify
among four conditions.
B. Features Designed for Specific Dermoscopic Criteria
Instead of general colour and texture-based image features,
some works specifically design features to capture known
salient properties of a skin condition. This is common in
melanoma classification, where the presence of specific dermo-
scopic criteria suggests melanoma (Section I-C2). For exam-
ple, in order to detect blue-white veils in dermoscopy images,
Madooei et al. [59] matched the lesion colours to a template
of common blue-white veil colours. To detect and classify
the types of streaks within dermoscopy images, Mirzaalian et
al. [60] used a filter designed to capture the tubular properties
of streaks. They segmented lesions using graph cuts [61],
and used features derived from the detected streaks to train
an SVM to distinguish the type of streaks. Fabbrocini et
al. [62] designed separate pipelines and engineered features to
classify seven dermoscopic criteria. For example, to classify
irregular streaks, they segmented the lesion and compared the
irregularity at the border to a reference threshold.
C. Learned Features of Dermatological Images
Rather than general engineered or features designed to target
specific dermatological criteria, features can be learned from
the data. In order to classify melanoma from non-melanoma
in dermoscopy images, Codella et al. [63] applied an unsuper-
vised sparse coding approach [64] to learn a sparse number of
patterns that minimized an image reconstruction error. They
also passed dermoscopy images into a CNN that was trained
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over the natural images (e.g., cats and dogs) of ImageNet [65],
and extracted the CNN responses from select layers to use as
feature vectors. They found that using these learned features to
train an SVM gave a similar level of classification performance
when compared to the previous state-of-the-art approach of
using an ensemble of general engineered features. Over the
clinical images of Dermofit (Sec. I-D2), Kawahara et al. [66]
found that training a logistic regression classifier on features
extracted from a pretrained CNN outperformed previously
published approaches that relied on the classical pipeline and
general engineered features.
Learning features directly from the images can also sim-
plify the overall pipeline (Fig. 4) as this approach does not
rely on engineered image features that require careful lesion
segmentation (e.g., computing features at the border of the
lesion). Avoiding lesion segmentation may be desirable as
segmentation is challenging [67]. For example, 16% of the
lesions segmented by the top performing lesion segmentation
method of the 2017 ISIC challenge had a Jaccard Index
of less than 0.6, which is considered a failure [28]. These
segmentation errors may propagate to errors in the features,
which may decrease classification performance.
D. Joint Optimization to Learn Features and Classify
The approaches described so far extract fixed features from
the images f(x), and perform a separate optimization for
classification,
θ∗ = argmin
θ
E (φ(f(x); θ), y) (11)
where φ(·) is a user specified classifier (e.g., SVM, logistic re-
gression classifier) parameterized by θ. The parameters learned
when optimizing Eq. 11 are based on the fixed (possibly
learned) set of image features f(x), under the assumption that
they will prove useful for classification. This section looks
at works that combine feature learning and classification in a
single optimization.
Deep learning [68] involves training a model composed of
stacked layers of trainable parameters that learn non-linear
feature representations of the data. Deep learning is widely
used in skin lesion analysis, with the organizers of the 2017
ISIC skin challenge [28] (Section I-D4) noting that among
the entries of this public challenge:
“All top submissions implemented various ensem-
bles of deep learning networks.”
One type of deep learning model well suited for image clas-
sification is the CNN. The structure of the CNN considers the
properties of images (locality of features, spatial invariance)
and learns to transform the image pixels into discriminative
feature representations. As all parameters within the CNN are
learned, a CNN can be thought of as “synthesizing their own
feature extractor” [69].
In this approach, a human designed CNN architecture φ(·) is
chosen, and an explicit optimization algorithm finds the CNN’s
parameters,
θ∗ = argmin
θ
E (φ(x; θ), y) . (12)
In contrast to Eq. 11, this equation does not have the human
chosen representation of the features (i.e., f(·) in Eq. 11).
Rather, the parameters to compute the features, and the pa-
rameters to classify are learned within a single optimization.
There are many possible error functions E(·), but a common
choice for classification (others discussed in Sec. II-D2) is the
categorical cross-entropy loss function,
E(p, y) = − 1
N
N∑
i=1
C∑
j=1
y
(i)
j log(p
(i)
j ) (13)
where N is the number of images, C is the number of classes
(e.g., types of skin diseases), y(i)j is a one-hot encoded ground
truth label, and p(i)j is the predicted j-th class probability for
the i-th image. Stochastic gradient descent can be used to learn
the parameters θ that minimize Eq. 12, where the parameters
θ of the model φ are iteratively updated [69].
1) CNNs for Classifying Skin Diseases: Many works
(e.g., [70]–[72]) that use CNNs to classify skin diseases rely
on CNN architectures (e.g., VGG16 [73]) that perform well
when classifying natural images (e.g., ImageNet [65]). The
parameters of the CNN learned over the natural images are
stored (referred to as a pretrained CNN) and are used to
initialize the weights of the CNN before training on a different
target domain, such as skin images. The process of refining
the learned parameters to a new target domain is referred to
as transfer-learning or fine-tuning the CNN.
While several CNN approaches ignore lesion segmen-
tations [70]–[72], which simplifies the overall pipeline
(Sec. II-C), explicitly localizing the skin lesion prior to training
a CNN may reduce distracting background artefacts and im-
prove overall performance. Yoshida et al. [74] trained a CNN
to classify melanoma from nevi using dermoscopy images,
where the major axis of each lesion was aligned in order to bet-
ter capture the lesion asymmetry that is commonly associated
with melanoma. A CNN trained using image augmentations
that were constrained to maintain this alignment outperformed
a CNN trained on non-aligned lesions when the same amount
of image augmentation was performed. Yu et al. [75] used
a two-step process where the lesion is first segmented using
a fully-convolutional neural network trained to segment skin
lesions, then the lesion is cropped based on this segmentation
and passed to a CNN for classification. Using this approach,
Yu et al. [75] ranked first place on the ISBI-ISIC 2016 skin
lesion classification challenge (Sec. I-D4).
Although deep neural networks are often used to classify
skin lesions [28], not all groups report better performance
when compared to using a separate feature extraction and
classification approach (Eq. 11). Sun et al. [32] collected
6,584 clinical and dermoscopy skin images, spanning 198
classes of common skin diseases from an online source. They
trained an SVM on general engineered features and achieved
a classification accuracy of 52.19% over the 198 classes,
outperforming the 50.27% accuracy achieved using a CNN
(VGG16 [73]) pretrained over ImageNet and fine-tuned to
classify the skin conditions. A similar result was also found
by Yang et al. [76].
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Ge et al. [77] represented skin images as concatenated l2-
normalized responses from ResNet-50 [78] and VGG16 [73]
fine-tuned on skin images. They extracted features using
compact bilinear pooling [79], and trained an SVM to classify
among 15 types of skin diseases using skin lesions acquired as
both a clinical and dermoscopy image, outperforming a single
fine-tuned CNN. They summed the predicted probabilities
from each imaging modality together to form a final prediction
accuracy of 71%. They used 24,182 training images and 8,012
testing images from an internal dataset known as “MoleMap”.
2) Other Classification Loss Functions: Cross-entropy is a
common loss function used to train a CNN (Eq. 13); however,
other losses are also used. Ge et al. [80] incorporated clinical
and dermoscopy images into a single CNN model trained to
minimize the mean squared loss between the predicted and
true vectors, and reported only minor differences in overall
performance when compared to the cross-entropy loss. They
used class activation maps [81] to find salient areas of the
image, and extracted dense features from the diseased area
using bilinear pooling [79]. They achieved a classification
accuracy of 70% accuracy over 15-classes.
Demyanov et al. [45] trained a CNN using a tree-loss func-
tion that incorporated a human defined skin disease taxonomy.
This taxonomy allows data to be labeled with different gran-
ularities. For example, a lesion could have the general label
of “benign” (coarse granularity) and the more specific label
of “blue nevus” (fine granularity). Using an internal dataset
of 40,173 dermoscopy and clinical images, composed of 15
skin conditions, they trained ResNet-50 [78] using their tree-
loss function and obtained 64.8% accuracy, demonstrating a
small but consistent improvement to accuracy when compared
to training without the tree-loss function.
E. Incorporating Non-Visual Information
While our focus in this survey is on visual classification,
other non-visual information may provide important context
when classifying skin diseases. Razeghi et al. [82] collected
answers that humans gave to 37 simple questions about skin
images (e.g., is the patient an infant, child, or adult?), as
well as extracted general engineered features from the images.
Using 2,309 clinical images from an online source composed
of 44 disease types, they manually placed a bounding box
around the lesion in the image, and trained a random forest
to classify the skin diseases. Using only visual information, a
trained random forest yielded 15.76% accuracy. Using only the
human given answers to questions yielded 16.58% accuracy,
and combining both yielded 25.12% accuracy. Kawahara et
al. [83] incorporated clinical images, dermoscopy images,
and patient meta-data (e.g., lesion location, sex) in a single
CNN model designed to jointly classify multiple types of
dermoscopic clinical criteria (e.g., type of streaks) and skin
disease diagnoses. This approach reached an average classifi-
cation accuracy of 73.7% when classifying skin diseases and
dermoscopic criteria, which was an improvement over training
on a single modality.
F. Image Retrieval
Adopting machine diagnoses into clinical practice may be
hindered if the model does not offer an intuition into how the
diagnoses are made. One approach towards more interpretable
models is to retrieve images of known diseases that are visually
similar to a user’s lesion, allowing a user to visually inspect
similar images of known diseases and infer a diagnosis.
Given a test query image q, the goal of image retrieval is
to find the image x(i) within a dataset of known skin diseases
that is most similar to the query image q. The corresponding
known label y(i) is used as the prediction yˆ(i) for the unknown
query image,
x(i), y(i) = argmin
i∈{1,...,N}
D(f(q), f(x(i))) (14)
where N is the number of samples in the labelled dataset,
f(x(i)) computes the features for the i-th image of the labelled
dataset, and D(a, b) measures the dissimilarity (e.g., cosine
distance) between two feature vectors. A variation on this
approach is to find the k > 1 most similar images and a
corresponding ranked list of diagnoses.
Celebi et al. [84] retrieved similar skin images using shape
features extracted from segmented lesions and weighted these
features to match the human perception of similar lesion
shapes. Ballerini et al. [85] extracted colour and texture
features from skin lesions, selected and combined features
using a genetic algorithm, and retrieved up to k = 10 labelled
images that had the lowest distance D(·) (e.g., euclidean
distance) in feature space f(·) to a given query image. Bunte
et al. [86] proposed an image retrieval system that retrieved
dermoscopy images of similarly coloured lesions. They ex-
tracted colour-based features from manually selected patches
within the lesion and healthy skin, learned features based on
four classes of colours, and retrieved images using a k-nearest
neighbourhood, where k ranged from 1 to 25.
Kawahara et al. [87] used a minimal path approach to find
a progression of visually similar images between two query
images. This may be useful in finding images related to disease
progression (e.g., from benign to malignant). Skin lesions were
represented as nodes in a graph, with edges representing the
visual dissimilarity between lesions in a feature space based
on the responses of a pretrained CNN.
Kawahara et al. [83] fine-tuned a pretrained CNN to classify
both the disease and the 7-point checklist criteria [15]. They
used the CNN layer responses f(·) to represent images and
retrieved the class from the image with the lowest cosine
distance D(·) to a query image. Over five classes of skin dis-
eases, they reported an averaged retrieval accuracy of 71.1%.
Tschandl et al. [88] used a similar approach for dermoscopy
images and found that image retrieval had comparable accu-
racy with classification and allowed for better recognition of
diseases that occur in datasets that the CNN was not trained
on.
III. DERMATOLOGIST AND MACHINE PERFORMANCE
This section examines works that report the skin lesion clas-
sification performance of human dermatologists and machines
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from the same dataset. Dermatology studies that report lesion
diagnosis via static images are also reported.
A. Ground Truth for Dermatologists’ Classifications
Studies that measure human performance have dermatolo-
gists make diagnoses based on the provided static informa-
tion (e.g., images, curated patient history). These diagnoses
are compared to the “ground truth” class labels, which are
determined by more rigorous diagnoses procedures. These
procedures vary, but often consists of diagnoses by histopathol-
ogy, a consensus of experts, interactive face-to-face sessions
between dermatologists and patients, or a combination of
approaches [30].
B. Dermatologists Compared with Machine
Ferris et al. [89] manually segmented skin lesions, extracted
shape, colour, and texture based features, and trained a de-
cision forest over 273 dermoscopy images, and tested the
classification performance on 40 benign and 25 malignant
dermoscopy images. Over the same test dataset of 65 lesions,
30 clinicians had an averaged melanoma sensitivity of 70.8%
and specificity of 58.7%, whereas the automatic classifier had
a melanoma sensitivity of 96% and specificity of 42.5%.
Codella et al. [90] and Marchetti et al. [91] compared an
ensemble of top performing machine classification approaches,
which included CNNs, to the average of eight dermatologists.
Over 100 dermoscopy test images, the automated system
achieved a higher accuracy (76%) than dermatologists (70.5%)
when classifying 50 melanoma from 50 benign neoplasm
images [90]. The eight dermatologists achieved an averaged
sensitivity of 82% and specificity of 59%, while five top per-
forming automated approaches on the ISIC-2016 challenges
achieved a voting average sensitivity of 56% and specificity
of 90%.
Esteva et al. [41] collected a dataset of 129,450 clinical im-
ages, which included 3,374 dermoscopy images, and spanned
across 2,032 types of skin diseases. They grouped classes
together based on their clinical similarity as per a human-
defined taxonomy, which yielded 757 partitions (classes) for
training. They used the Inception-V3 architecture [92], pre-
trained over ImageNet [65], and fine-tuned the model on
the partitioned classes. They reported results over different
levels of the taxonomy, where the sum of the predicted
probabilities in the descendant nodes determined the higher
level classes predicted probabilities. Over a nine-class partition
of dermatologist inspected images (i.e., may not be verified
via histopathology), the CNN achieved an overall skin disease
classification accuracy of 55.4%, which is comparable to the
accuracy achieved by two dermatologists (53.3% and 55.0%).
To compare a CNN with humans in similar training con-
ditions, Tschandl et al. [93] showed 298 dermoscopy im-
ages from six different lesion classes to 27 medical students
(without prior dermoscopy experience), and provided only
the corresponding diagnosis of each image without explaining
the diagnostic features. The same images were used to fine-
tune an Inception-V3 CNN architecture [92] pretrained over
ImageNet, where the last layer was replaced to match the
target classes. Both the students and CNN then diagnosed the
diseases from 50 test images. The CNN achieved a diagnostic
accuracy of 69% and was reported to demonstrate a similar di-
agnostic agreement as the average agreement among students.
When diagnosing malignant lesions (basal cell carcinoma and
melanoma) from benign, the CNN achieved a higher sensitivity
(90% for CNN, 85% for students), but lower specificity (71%
for CNN, 79% students) than the students’ average scores.
Han et al. [94] formed a dataset of 49,567 hand and foot
nail images by using manually labelled data, assisted by first
training a hand and foot CNN classifier, followed by a region-
CNN [95] trained to localize the nail plate, and an image
quality CNN that eliminates poor quality nail images. They
showed that a CNN could classify nail images that contain
onychomycosis (a nail fungal infection) from other nail disor-
ders with a higher Youden Index (sensitivity + specificity - 1)
(67.62%) than then the average of 42 human dermatologists
(48.39%) over 1133 images.
Han et al. [42] fine-tuned a pretrained CNN (ResNet-
152 [78]) on 19,389 manually cropped clinical images taken
from primarily an Asian population (Asan dataset). The train-
ing dataset was composed of 248 classes of skin diseases,
while testing was done on an aggregated 12-class subset. The
CNN tested over images from an Asian population achieved
an accuracy of 57.3%, and 55.7% over the 12-classes of the
Asan dataset, and the 10-classes of Dermofit (Sec. I-D2),
respectively. Additional experiments comparing the diagnoses
of 16 dermatologists over a subset of these images had, in
general, a ROC curve inside the ROC curve produced by the
CNN.
Yang et al. [76] had general doctors, junior dermatologists,
and expert dermatologists classify skin images from 198
classes of skin diseases. Two doctors from each category
were invited to independently classify images and discuss
the diagnosis when they differed. The accuracy was 49.00%
for general doctors, 52.00% for junior dermatologists, and
83.29% for expert dermatologists. The accuracy of the top
performing CNN was 53.35%, which was lower than the
expert dermatologists, but comparable with general doctors
and junior dermatologists.
Haenssle et al. [96] trained a CNN to classify dermoscopy
images as either a benign nevi or melanoma using training
images from a variety of sources. Using 100 test dermoscopy
images, they compared the classification results of the CNN
with 58 dermatologists. On average, dermatologists had a
sensitivity of 86.6% and specificity of 71.3%, while a CNN
tested over the same images achieved a sensitivity of 95% and
specificity of 63.8%.
Brinker et al. [97] compared the performance of 157
dermatologists with a CNN trained to classify melanoma
within dermoscopy images. Using 100 dermoscopy images,
the dermatologists had an averaged sensitivity to melanoma of
74.1% and averaged specificity of 60.0%. When the specificity
of the CNN was set to 74.1% the CNN achieved a specificity
of 86.5%.
Fujisawa et al. [98] fine-tuned a pretrained CNN on clinical
images to classify among 21 disease classes and aggregated the
predicted classes within a skin tree hierarchy. Using the diag-
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noses aggregated at the third level of the tree with 14 classes,
the CNN achieved an accuracy of 76.5%, outperforming the
averaged diagnostic accuracy of 13-board certified dermatolo-
gists (59.7%) and nine dermatology trainees (41.7%).
Tschandl et al. [99] combined the predictions from a CNN
trained on dermoscopy and a CNN trained on clinical close-
up images to form a final diagnosis. When compared with
95 human examiners with varying levels of expertise [100],
the CNN had a higher number of correct specific diagnosis
(37.6%) than the human examiners (33.5%), but lower than
human expert dermatologists (40.0%).
C. Comparing Dermatologists on Static Images
To better estimate human performance, this section pri-
marily examines store-and-forward teledermatology studies,
where the patient data (e.g., lesion image, patient history) is
sent to a dermatologist for review [101],
To compare how different types of static images influences
human performance, Sinz et al. [100] had 95 human examiners
(including 62 dermatologists) classify 50 images randomly
sampled from 2,072 cases into one of 51 possible diagnoses.
Using clinical images, the averaged accuracy was 26.4%.
Using dermoscopy images, the averaged accuracy improved
to 33.1%, indicating that performance depends on the imaging
modality.
To compare in vivo diagnosis and diagnosis via static
images, Carli et al. [102] collected 256 lesions composed of
seven classes of biopsy verified diseases. Using the consensus
of two dermatologists (in disagreement, a third dermatologist
was consulted), they reported a diagnosis accuracy of 40.1%
during clinical examinations without dermoscopy. When in
vivo dermoscopy was incorporated with the clinical examina-
tion, the accuracy improved to 72.3%. The accuracy dropped
to 54.7% when the dermatologists had access to only the
dermoscopy photographs and patient history, but not clinical
information.
Weingast et al. [40] had 263 patients photograph their
own lesions, when possible, using a mobile camera, and
provide additional questionnaire information. They collected
a wide variety of skin conditions, which were typical of the
authors outpatient unit. Multiple teledermatologists reviewed
each case, and overall, 49% of the gathered cases could be
correctly diagnosed via teledermatology when compared to a
face-to-face consultation (a differential diagnosis was allowed
in some cases i.e., top-2 accuracy Eq. 1). The teledermatol-
ogists reported only 61% of the cases contained sufficient
information to make a diagnosis.
In a prospective study with 63 dermoscopy images,
Walker et al. [103] used a CNN to extract visual feature
representations that were converted into sound and visually or
audibly analyzed by humans to detect cancerous skin lesions,
achieving a sensitivity of 86% and specificity of 91%.
Brinker et al. [39] had 157 dermatologist assess 100 der-
moscopy images and 145 dermatologists assess 100 clinical
images composed of nevi and melanoma skin lesions. Derma-
tologists provided a management decision (biopsy vs. reassure
patient), achieving an average of 74.1% sensitivity and 60.0%
specificity for dermoscopy images; and, 89.4% sensitivity and
64.4% specificity for clinical images.
IV. DISCUSSIONS
This section lists the challenges of comparing across stud-
ies, summarizes the reported performance of selected human
and machine skin disease classification works, and discusses
potential limitations and sources of error within image-based
diagnoses of skin conditions.
A. Challenges of Metrics and Comparing Skin Studies
This section primarily focused on the metric of diagnostic
accuracy as it is commonly reported (or can be inferred) in
both clinical and computer vision studies, and it gives us
a single intuitive metric for multi-class problems. However,
relying on diagnostic accuracy assumes that all errors are
equal, which may hide a poor performance on infrequently
occurring diseases. Other metrics, such as averaged diagnostic
sensitivity or precision, address the class imbalance problem
by giving an equal weighting to each class, resulting in a
higher weighting of infrequent conditions. All these metrics
are limited since clinically, some conditions are more impor-
tant to correctly diagnose than others (e.g., a false-negative
melanoma diagnosis can be fatal). One potential solution is
to weight each misdiagnosis to account for the severity of a
misdiagnosis. However, establishing such a clinical weighting
is non-trivial for multi-class problems, and would require
significant expert knowledge.
Another approach is to ignore diagnostic performance and
instead focus on predicting appropriate treatments (e.g., man-
agement strategies [100]). While this considers the clinical
implications of a disease, it requires a consensus on ap-
propriate treatments, which may change as new treatments
become available. Another complication is illustrated in the
case of melanoma, where images that are biopsy verified
are, by definition, ones that a dermatologist recommended for
biopsy. Thus, biopsy images labeled as benign are clinically
suspicious enough that an expert flagged them for biopsy.
One may question if the goal of machine classification should
be to replicate the dermatologist’s decision or to classify the
underlying disease.
A limitation in comparing across studies is that the difficulty
of diagnosing diseases depends on the dataset (e.g., some
diseases display more consistent morphology), making it
unclear if one particular methodology performs better of if
the differences are due to the datasets. Studies that compare
the performance of both humans and machine (Sec. III-B)
often compare over the same dataset, allowing for a fairer
comparison.
Nevertheless, with these limitations stated, diagnostic accu-
racy is used as our primary metric, largely due to insufficient
information provided in many studies to infer other metrics
and the challenges associated with choosing a single more
descriptive metric. Results are aggregated across different
studies, composed of a variety of datasets, in order to compare
the performance of humans and machines.
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B. Comparing Human and Machine Performance
Table V shows 45 skin condition classification experiments
selected from 22 studies, spanning both clinical and computing
research. The works in this table were selected based on the
following criteria: 1) they compared humans and machines
over the same dataset, or 2) they reported human and machine
performance separately on a multi-class (greater than two)
dataset. Experiments where the predictions (Eq. 9) of a model
could not be inferred were omitted. This primarily occurred
when only the AUROC scores were reported.
As not all studies report accuracy, accuracy was inferred
given the other reported metrics. Occasionally, the exact sensi-
tivity and specificity were not given, and these were estimated
from the reported graphs. For studies that had predictions made
by multiple humans, the accuracy was computed using the
average human performance.
Table V reports the dataset and the number of images used
to evaluate, the input modality, whether human or machines
did the diagnosis, the number of classes, and the accuracy
over the entire test set. Fig. 5 plots the number of classes
versus the reported accuracy, separated based on machine and
human skin disease classification performance. A general trend
is observed, where as the number of classes increases, the
accuracy decreases.
Similar accuracy is found when averaged across studies for
both humans and machines (Fig. 6). As well, Fig. 7 highlights
that the inclusion of patient history (e.g., questionnaire, age,
sex) yields small changes to accuracy, with the exception of
one non-deep learning study that included 37 user supplied
answers [82].
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Fig. 5: Skin disease classes versus reported model accuracy.
Each coloured dot represents a experiment from Table V,
where the diagnosis was made by either a human or machine.
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Fig. 6: Averaged accuracy of the experiments in Table V,
grouped by the number of classes. On average, similar per-
formance of both human and machines is reported.
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Fig. 7: Averaged accuracy of the experiments in Table V,
grouped by the number of classes. Similar accuracy is reported
when additional meta data (i.e., patient history) is included in
the diagnosis.
C. Limitations and Sources of Errors in Image-Based Diag-
nosis
When developing an image-based classification system,
there are several limitations and sources of potential errors.
The “ground truth” disease labels may have errors, even when
confirmed via histopathology. Monheit et al. [104] found that
due to conflicts in the expert histopathology diagnoses, 8.8%
of lesions required more than two histopathological evalua-
tions before reaching a final diagnosis. Elmore et al. [105]
collected 240 biopsy cases and used the consensus of three
human experts to label each case into one of five cate-
gories that indicated a progressively increasing melanoma risk.
These consensus labels were compared to diagnoses given
by 187 pathologists, and the authors found that the three
diagnoses categories spanning “moderately dysplastic nevi to
early stage invasive melanoma were neither reproducible nor
accurate” [105].
Patients may be limited by their ability to capture high
quality images. Weingast et al. [40] had patients attempt
to acquire an image of their own lesion using a mobile
phone camera. However, 81% of patients required assistance
in acquiring images, partly due hard-to-reach lesions, and
challenges in focusing and choosing an appropriate field-of-
view. Even with assistance, 39% of the cases were reported
to have insufficient information to make a diagnosis via tele-
dermatology (but could be diagnosed face-to-face), indicating
significant challenges in acquiring quality images.
Images may contain insufficient or misleading informa-
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TABLE V: Selected skin disease classification approaches and diagnostic performance. N.Images indicates the number of
images in the dataset. N.Test indicates the number of images used to test (includes cross-validation). Derm., Clinic., and Meta.
indicate dermoscopy images, clinical images, and non-image patient history (meta-data), respectively, where a star (*) indicates
in vivo data. H.vs.M indicates if the diagnosis was made by a human or machine. Acc. indicates diagnostic accuracy.
Year Dataset N.Images N.Test Derm. Clinic. Meta H.vs.M Classes Acc.
[89] 2015 Internal - 65 X human 2 63.35
[89] 2015 Internal 273 65 X machine 2 63.08
[90] 2017 ISIC-100 - 100 X human 2 70.50
[90] 2017 ISIC-100 1000 100 X machine 2 76.00
[96] 2018 Internal - 100 X human 2 74.40
[96] 2018 Internal - 100 X X human 2 78.30
[96] 2018 Internal 100 X machine 2 81.60
[94] 2018 Asan - 1133 X human 2 75.80
[94] 2018 Asan 49,567 1133 X machine 2 80.00
[97] 2019 ISIC-100 13737 100 X machine 2 84.02
[39] 2019 ISIC-100 - 100 X human 2 62.82
[39] 2019 MED-NODE - 100 X human 2 69.40
[41] 2017 Stanford - 180 X X human 3 65.78
[41] 2017 Stanford 127,463 127,463 X X machine 3 72.10
[22] 2013 Dermofit 960 960 X machine 5 74.30
[83] 2018 Atlas 2018 395 X X machine 5 71.10
[83] 2018 Atlas 2018 395 X X X machine 5 73.70
[93] 2017 Internal 348 50 X human 6 74.00
[93] 2017 Internal 348 50 X machine 6 69.00
[102] 2002 Internal - 256 X* X* human 7 40.62
[102] 2002 Internal - 256 X X human 7 54.69
[102] 2002 Internal - 256 X* X* X* human 7 72.27
[41] 2017 Stanford - 180 X X human 9 54.15
[41] 2017 Stanford 127,463 127,463 X X machine 9 55.40
[57] 2015 Dermofit 1300 1300 X machine 10 67.00
[66] 2016 Dermofit 1300 1300 X machine 10 81.80
[42] 2018 Dermofit 20,689 1300 X machine 10 55.70
[42] 2018 Asan 19,389 1,276 X machine 12 57.30
[98] 2019 Internal - 1260 X human 14 41.70
[98] 2019 Internal - 1820 X human 14 59.70
[98] 2019 Internal 6009 1142 X machine 14 76.50
[45] 2017 MoleMap 40,173 1776 X X machine 15 69.10
[80] 2017 MoleMap 26584 7975 X machine 15 61.20
[80] 2017 MoleMap 26584 7975 X machine 15 61.30
[80] 2017 MoleMap 26584 7975 X X machine 15 70.00
[77] 2017 MoleMap 32,194 8,012 X X machine 15 71.00
[82] 2014 dermis 2309 1429 X machine 44 15.76
[82] 2014 dermis 2309 1429 X X machine 44 25.12
[100] 2017 Internal - 2072 X human 51 26.40
[100] 2017 Internal - 2072 X human 51 33.10
[32] 2016 SD-198 6,584 3292 X machine 198 52.19
[76] 2018 SD-198 - X human 198 49.00
[76] 2018 SD-198 - X human 198 52.00
[76] 2018 SD-198 - X human 198 83.29
[76] 2018 SD-198 6584 3292 X machine 198 56.47
tion easily resolved during a face-to-face examination. In
Sec. III-C, the reported differences in human diagnosis per-
formance during teledermatology suggests that diagnosing via
static images may be significantly more challenging than
diagnosis during face-to-face consultations. A further example
is given by, Hogan et al. [106] who documented a patient
supplied image that appeared to contain serious complications,
but on a face-to-face inspection revealed a crust covering a
well-healing wound. Thus, claims that machines have reached
human-level diagnostic ability should be considered in the
context of static images.
The role non-visual information (e.g., patient history, ques-
tionnaire data) takes in the diagnostic procedure and what
information should be gathered is not clear. Machine diagnoses
systems that do utilize non-visual patient data report a mixed
impact to performance, ranging from minimal [83] to substan-
tial improvements [82]. Experienced dermatologists exhibit
minimal improvements to diagnosis when given patient history
(age, sex, body location site) in addition to an image, but
those with less experience show a greater improvement with
access to patient history [96]. Acquiring this data outside of
face-to-face consultations may also be challenging. Weingast
et al. [40] reported that most patients over 60 years needed
assistance completing a computer questionnaire.
Another consideration is how transferable across datasets
and populations the models are. Han et al. [42] report an
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accuracy of 55.7% over the 10-classes of Dermofit. This is
significantly lower than other reported works that train and
test only over Dermofit (e.g., 81% [66]). As Han et al. [42]’s
model was trained on an Asian population and tested on a
European population, this drop in accuracy may be due to the
differences in how skin diseases manifest across populations,
or signify a lack of transferability in learned features across
datasets due to image acquisition protocols, or both.
These sources of errors and limitations are potentially
compounding, where ground truth errors in training, may
compound with low quality acquired images, and a lack of
model transferability across populations.
V. CONCLUSIONS
While there are still significant challenges in skin disease
diagnosis, in 2017 dermatologists from a variety of institutions
wrote the following statement [3]:
“With the physician workforce projected to remain
relatively flat, the specific ratio of dermatologists
to population will decrease over time, especially
in rural areas. These projections indicate a current
and future challenge to ensure patient access to
appropriate dermatologic care.”
Automated analysis of skin conditions has the potential to al-
leviate the diagnostic requirements of dermatologists, making
this a field worthy of investigation.
Given that recent studies report comparable accuracy per-
formance when comparing dermatologists and machines, and
considering the reported performance across independent tele-
dermatological and machine studies, it is reasonable to con-
clude that machine accuracy is nearing the performance of
human dermatologists in a teledermatological scenario. How-
ever, given the differences in performance when dermatolo-
gists diagnose via teledermatology [40], machine classification
accuracy may be significantly lower than a face-to-face con-
sultation with a dermatologist. As the diagnostic performance
of general practitioners is reported to be twice as low as
dermatologists [4], machine classification of skin diseases may
have increased utility among general practitioners, who are
often the first clinicians to examine dermatological disorders.
We highlight that when humans classify among the 1000-
classes of the natural images within ImageNet, the reported
top-5 error (considers a match in any of the top-5 predictions
to be correct) is 5.1%-12% [65]. While not directly comparable
due to the different number of possible classes considered, the
relatively low accuracy for humans classifying skin diseases
commonly reported in Table V indicates the challenges of
classifying skin diseases from images. Finally, we note that
diagnostic accuracy, which is focused on in this review, gives
us a limited understanding of performance, and does not
consider the severity of misdiagnosing certain conditions.
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